Cannabis Bioscience International Holdings (CBIH) Receivables - Net (2023 - 2026)
Cannabis Bioscience International Holdings filings provide 4 years of Receivables - Net readings, the most recent being $1266.0 for Q1 2026.
- On a quarterly basis, Receivables - Net fell 52.05% to $1266.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $1266.0, a 52.05% decrease, with the full-year FY2025 number at $6380.0, down 68.32% from a year prior.
- Receivables - Net reached $1266.0 in Q1 2026 per CBIH's latest filing, down from $21811.0 in the prior quarter.
- The five-year high for Receivables - Net was $21811.0 in Q4 2025, with the low at $1266.0 in Q1 2026.
- A 4-year average of $12599.3 and a median of $13819.0 in 2024 define the central range for Receivables - Net.
- Year-over-year, Receivables - Net soared 102.38% in 2024 and then tumbled 84.51% in 2025.
- Year by year, Receivables - Net stood at $19403.0 in 2023, then decreased by 28.78% to $13819.0 in 2024, then soared by 57.83% to $21811.0 in 2025, then crashed by 94.2% to $1266.0 in 2026.
- Per Business Quant, the three most recent readings for CBIH's Receivables - Net are $1266.0 (Q1 2026), $21811.0 (Q4 2025), and $8966.0 (Q3 2025).